Company Sponsored Symposium 1: FDA Symposium: Allergen Immunotherapy: What We Know and Unmet Needs
1-1CSS: Allergen Mixtures for Monosensititzed and Polisensitized Patients
1-1CSS: Allergen Mixtures for Monosensititzed and Polisensitized Patients
Plenary Session 1: Immunotherapy and Immunological Aspects of Allergic Disease
1-1PS: Biologic Basis of the Allergic Response
1-1PS: Biologic Basis of the Allergic Response
Postgraduate Course 1: Food Allergy Track - Diagnosis of Food Allergy
1-2PG: Component Testing for Food Allergy
1-2PG: Component Testing for Food Allergy
Symposium 1: The Microbiome: Link Between the Airways?
1-3SY: Epithelial Cells in Asthma Pathogenesis
1-3SY: Epithelial Cells in Asthma Pathogenesis
Plenary Session 2: Clinical Aspects of Sublingual Immunotherapy and Subcutaneous Immunotherapy
2-1PS: Subcutaneous Immunotherapy
2-1PS: Subcutaneous Immunotherapy
Plenary Session 2: Clinical Aspects of Sublingual Immunotherapy and Subcutaneous Immunotherapy
2-2PS: Novel Approaches to Immunotherapy
2-2PS: Novel Approaches to Immunotherapy
Symposium 2: The Expanding Role of the Allergist as Biologist
2-2SY: The Allergist as Virologist: The Role of Rhinovirus in the Pathogenesis of Asthma Exacerbations
2-2SY: The Allergist as Virologist: The Role of Rhinovirus in the Pathogenesis of Asthma Exacerbations
Postgraduate Course 2: Immunotherapy Track - Immunotherapy in the 21st Century
2-3PG: What is the Preferable Route?
2-3PG: What is the Preferable Route?
Company Sponsored Symposium 3: Takeda Symposium: Current and Future Trends in Allergic Rhinitis Management
3-1CSS: The Burden, Impact and Diagnosis of Allergic Rhinitis
3-1CSS: The Burden, Impact and Diagnosis of Allergic Rhinitis
Postgraduate Course 4: Basic Immunology and Immunodeficiencies Track - Primary Immunodeficiencies (PIDS)
4-1PG: Newly Identified Primary Immunodeficiencies
4-1PG: Newly Identified Primary Immunodeficiencies
Symposium 5: Latin American Society of Allergy and Immunology (SLAAI) Symposium: Immunotherapy in Latin America
5-3SY: Immunotherapy in Children: Sublingual Immunotherapy (SLIT) or Subcutaneous Immunotherapy (SCIT)
5-3SY: Immunotherapy in Children: Sublingual Immunotherapy (SLIT) or Subcutaneous Immunotherapy (SCIT)
Postgraduate Course 7: Food Allergy Track - Prevention of Food Allergy
7-1PG: Prevention of Food Allergy
7-1PG: Prevention of Food Allergy
Symposium 7: Anaphylaxis: Update
7-1SY: 2014 Update of the Evidence Supporting WAO Anaphylaxis Guidelines Recommendations
7-1SY: 2014 Update of the Evidence Supporting WAO Anaphylaxis Guidelines Recommendations
Postgraduate Course 8: Immunotherapy Track - Special Issues on Allergen-Specific Immunotherapy
8-2PG: Adverse Reactions to Immunotherapy
8-2PG: Adverse Reactions to Immunotherapy
Postgraduate Course 9: Upper and Lower Airways Track - Small Airway Inflammation: Diagnosing, Monitoring and Treating
9-1PG: Recognizing Small Airway Dysfunction by Impulse Oscillometry and Exhaled Nitric Oxide in Asthmatics
9-1PG: Recognizing Small Airway Dysfunction by Impulse Oscillometry and Exhaled Nitric Oxide in Asthmatics
Symposium 9: Portuguese Session: Asthma and Anaphylaxis in Children and Adolescents: Challenges in Diagnosis and Treatment
9-2SY: Role of Respiratory Viruses in Childhood Wheeze: Insights from Brazilian Studies
9-2SY: Role of Respiratory Viruses in Childhood Wheeze: Insights from Brazilian Studies
Postgraduate Course 9: Upper and Lower Airways Track - Small Airway Inflammation: Diagnosing, Monitoring and Treating
9-3PG: Treatment of Small Airway Disease: When, How, How Long?
9-3PG: Treatment of Small Airway Disease: When, How, How Long?
Postgraduate Course 10: Basic Immunology and Immunodeficiencies Track - Advances in the Diagnosis and Management of Primary Immunodeficiency (PID)
10-3PG: Pulmonary Complications in PID
10-3PG: Pulmonary Complications in PID
Symposium 11: Update in Pediatric Asthma Treatment
11-2SY: Are Intermittent Inhaled Steroids an Effective Option to Treat Asthma in Children?
11-2SY: Are Intermittent Inhaled Steroids an Effective Option to Treat Asthma in Children?
Symposium 11: Update in Pediatric Asthma Treatment
11-3SY: How can we Treat Viral-Induced Wheezing in Preschool Children?
11-3SY: How can we Treat Viral-Induced Wheezing in Preschool Children?
Symposium 12: New Insights in Airways Eosinophilic Inflammation
12-2SY: Are all TH2 Inflammations the Same?
12-2SY: Are all TH2 Inflammations the Same?
Postgraduate Course 13: Food Allergy Track - Treatment of Food Allergy
13-1PG: Oral Immunotherapy and Sublingual Immunotherapy
13-1PG: Oral Immunotherapy and Sublingual Immunotherapy
Symposium 13: Asthma and Allergy in Children
13-2SY: Rhinovirus Wheezing Illness and the Risk of Childhood-Onset Asthma
13-2SY: Rhinovirus Wheezing Illness and the Risk of Childhood-Onset Asthma
Symposium 13: Asthma and Allergy in Children
13-3SY: Challenges in Diagnosing Allergic Triggers in Childhood Asthma
13-3SY: Challenges in Diagnosing Allergic Triggers in Childhood Asthma
Postgraduate Course 14: Immunotherapy Track - Cockroach Immunotherapy: New Insights
14-1PG: Cockroach Allergens: Overview of Structure and Function
14-1PG: Cockroach Allergens: Overview of Structure and Function
Postgraduate Course 14: Immunotherapy Track - Cockroach Immunotherapy: New Insights
14-2PG: Environmental Assessment and Exposure Reduction of Cockroaches
14-2PG: Environmental Assessment and Exposure Reduction of Cockroaches
Symposium 15: Allergists for Israel (AFI) Symposium: Update on Drug Hypersensitivity
15-1SY: Epidemiology of Drug Reactions in Latin America
15-1SY: Epidemiology of Drug Reactions in Latin America
Symposium 15: Allergists for Israel (AFI) Symposium: Update on Drug Hypersensitivity
15-3SY: Approach to Drug Desensitization in Outpatient and Inpatient Settings
15-3SY: Approach to Drug Desensitization in Outpatient and Inpatient Settings
Symposium 16: Biomarkers in Asthma: Helping Diagnosis and Treatment
16-1SY: Periostin: Update on Clinical Use
16-1SY: Periostin: Update on Clinical Use
Postgraduate Course 16: Basic Immunology and Immunodeficiencies Track - TH-22, Thymic Stromal Lymphopoietin (TSLP) and Fractalkine: New Targets in Atopic Dermatitis?
16-2PG: TSLP and In Situ Hemopoiesis in Allergic Inflammation
16-2PG: TSLP and In Situ Hemopoiesis in Allergic Inflammation
Postgraduate Course 17: Anaphylaxis and Drug Allergy Track - Drug Hypersensitivity Investigation
17-1PG: Non-Steroidal Anti-Inflammatory Drugs
17-1PG: Non-Steroidal Anti-Inflammatory Drugs
Postgraduate Course 19: Food Allergy Track - Food Allergy: Associated Conditions and Management
19-2PG: Eosinophilic Esophagitis: Pathogenesis and Role of Food Allergy
19-2PG: Eosinophilic Esophagitis: Pathogenesis and Role of Food Allergy
Postgraduate Course 20: Immunotherapy Track - New Developments in House Dust Mite Allergy
20-1PG: House Dust Mite Allergens: From Fecal Particles to Molecular determinants for Antibody Binding
20-1PG: House Dust Mite Allergens: From Fecal Particles to Molecular determinants for Antibody Binding
Symposium 22: World Allergy Congress (WAC) 2015 Symposium: Allergic Diseases in the Elderly
22-1SY: Epidemiology and Clinical Features of Asthma in the Elderly
22-1SY: Epidemiology and Clinical Features of Asthma in the Elderly
Symposium 22: World Allergy Congress (WAC) 2015 Symposium: Allergic Diseases in the Elderly
22-3SY: Chronic Urticaria and Atopic Dermatitis in the Elderly
22-3SY: Chronic Urticaria and Atopic Dermatitis in the Elderly